Valuation Northwest Biotherapeutics, Inc.

Stocks

Market Closed - OTC Markets 22:59:59 18/09/2026 +03			5-day change	1st Jan Change
0.1601 ^USD	-3.26%		-5.21%	-30.01%

08-14	Northwest Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Northwest Biotherapeutics and Saudi Pharmaceutical Industries and Medical Appliance Company Enter Memorandum of Understanding for Collaboration	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027
Market Cap ¹	364	358.4	273.1	-
Change	-	-1.53%	-23.81%	-
Enterprise Value (EV) ¹	364	358.4	369.2	398
Change	-	-1.53%	3%	7.82%
P/E	-3.93x	-5.72x	-	-
PBR	-	-	-	-
PEG	-	0.1x	-	-
Capitalization / Revenue	-	-	-	7.01x
EV / Revenue	-	-	-	10.2x
EV / EBITDA	-	-	-	-
EV / EBIT	-	-	-5.49x	-8.4x
EV / FCF	-	-	-7.24x	-9.77x
FCF Yield	-	-	-13.8%	-10.2%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-0.07	-0.04	-	-
Distribution rate	-	-	-	-
Net sales ¹	-	-	-	38.93
EBITDA	-	-	-	-
EBIT ¹	-	-	-67.3	-47.4
Net income	-85.19	-61.48	-	-
Net Debt ¹	-	-	96.08	124.9
Reference price ²	0.2748	0.2288	0.1601	0.1601
Nbr of stocks (in thousands)	1,324,666	1,566,728	1,705,638	-
Announcement Date	3/31/25 A	4/15/26 A	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NORTHWEST BIOTHERAPEUTICS, INC.	-	-	-	-	273M
WUXI APPTEC CO., LTD.	20.78x	7.37x	14.79x	1.43%	70.88B
ARGENX SE	48.85x	9.38x	29.23x	0.04%	62.49B
WUXI BIOLOGICS (CAYMAN) INC.	30.44x	6.47x	16.8x	-.--%	26.34B
INSMED INCORPORATED	-73.25x	14.16x	-68.28x	-.--%	26.21B
BIONTECH SE	-14.7x	5.35x	-6.73x	-.--%	24.13B
GENMAB A/S	28.25x	5.33x	17.72x	-.--%	20.72B
PHARMAESSENTIA CORPORATION	44.51x	16.33x	33.12x	0.34%	15.36B
EXELIXIS, INC.	18.03x	5.37x	12.55x	-.--%	14.46B
SUMMIT THERAPEUTICS INC.	-15.41x	3481.82x	-17.8x	-.--%	14.24B
Average	9.72x	394.62x	3.49x	0.2%	27.51B
Weighted average by Cap.	15.88x	188.47x	7.90x	0.4%